1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6FD1FE1A7C8AE1A9C6525799C00372FF0
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-innovative-practices-for-improving-healthcare-marketing-across-customer-groups?opendocument
18
19opendocument
2034.229.24.100
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Marketing Management Marketing Strategy

Innovative Practices for Improving Healthcare Marketing Across Customer Groups

ID: 5183


Features:

15 Info Graphics

38 Data Graphics

370+ Metrics


Pages/Slides: 63


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • SPECIAL OFFER
To broaden their marketing reach, biopharmaceutical companies are investing in innovative marketing strategies and tactics to engage key customer groups such as health care providers, patients, payers, and key opinion leaders. But as they shift to activities such as social networking, relationship marketing, e-sampling, viral marketing and other approaches, marketing groups are facing questions around structure, budgets, staffing and roles.


Best Practices, LLC conducted this research to identify how companies structure, staff and organize to find, use and quickly incorporate innovative practices to improve marketing across these customer groups. The results provided in this report include key benchmark metrics and lessons learned that biopharmaceutical marketing executives can utilize to enhance and optimize their current activities in innovative customer marketing.


Industries Profiled:
Pharmaceutical; Health Care; Diagnostic; Manufacturing; Biotech; Consumer Products; Medical Device; Chemical


Companies Profiled:
EMD Serono; Molnlycke Healthcare; Boehringer Ingelheim; Glenmark; GlaxoSmithKline; Gen-Probe; Bayer; Pfizer; Sanofi-aventis; Solvay Pharmaceuticals; Abbott; Bausch & Lomb; Quintiles; Dr Reddy's Laboratories; Werrick Pharmaceuticals; Takeda Pharmaceuticals; Medtronic; Merck; Steris Corporation; Novartis; Genentech; Bayer Healthcare; Endo Pharmaceuticals; Lilly; AstraZeneca

Study Snapshot

The benchmark class includes 35 representatives from 25 leading biopharmaceutical companies. In addition, 6 deep-dive executive interviews were conducted with selected participants to provide qualitative and quantitative insights.

Key topics include:

  • Project Overview
  • Summary of key insights
  • Organizational structure
  • Budgets and funding
  • Roles and responsibilities
  • Processes and procedures
  • Lessons learned

Sample Key Finding

Harness New Technology to Enable Innovation: New media and innovative communication practices represent new marketing frontiers. Regulatory pressures and the growing importance of access are important factors to ensuring that innovative practices are tested and measured for success.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.